ArticleHuman vaccines & immunotherapeutics2025

PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysis.

José Luis Huerta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.